ADAM17 and breast cancer: However, the axis of miR-338-3p (Up) in BC/ADAM17 secretion (Down)/granzyme B, CD16, and NKG2D (Down) inNK/NK cell function (Down)/BC survival (Up) ultimately resulted in an effect that increased BC cell survival [59].